Your search returned 75 studies. (Get alerts for new studies):
- A Novel Treatment for Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma
Conditions: Melanoma
1 Location available
- Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
2 Locations available
- Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Temozolomide or MEK Inhibitor AZD6244 (Selumetinib) in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
10 Locations available
- RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- Vaccine Therapy With or Without Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Conditions: Cutaneous Melanoma
1 Location available
- A Study of Vemurafenib in Metastatic Melanoma Patients With Brain Metastases
Conditions: Malignant Melanoma
8 Locations available
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Conditions: Metastatic Renal Cell Carcinoma - Metastatic Melanoma
2 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Conditions: Mucosal Melanoma - Acral/Lentiginous Melanoma
5 Locations available
- Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Phase II Study of Tesetaxel in Metastatic Melanoma
Conditions: Advanced Melanoma - Cancer
1 Location available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
1 Location available
- Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
16 Locations available
- A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotrheraphy Regimen
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients W
Conditions: Metastatic Melanoma
2 Locations available
- Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Conditions: Leukemia - Non-melanomatous Skin Cancer
3 Locations available
- Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Conditions: Metastatic Cancer - Metastatic Melanoma - Renal Cancer
1 Location available
- A Study of RO5185426 And GDC-0973 in Patients With BRAF-Mutation Positive Metastatic Melanoma
Conditions: Malignant Melanoma
6 Locations available
- Prospective Randomized Study of Cell Therapy for Metastatic Melanoma Using Short-Term Cultured Tumor Infiltrating Lymphocytes Plus IL-2 Following Eith
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
Conditions: Melanoma
5 Locations available
- Vaccination Plus Ontak in Patients With Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Interferon Alfa-2b in Treating Patients Who Have Undergone Surgery for High-Risk or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
Conditions: Melanoma - Liver Metastasis
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
Conditions: Skin Cancer - Metastatic Melanoma
1 Location available
- Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer
Conditions: Melanoma - Metastatic Kidney Cancer
2 Locations available
- Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
Conditions: Metastatic Melanoma - Skin Cancer
1 Location available
- Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Conditions: Melanoma - Metastatic Melanoma - Solid Tumor
2 Locations available
- A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Conditions: Melanoma
2 Locations available
- Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
Conditions: Melanoma
1 Location available
- RADVAX: A Stratified Phase I/II Dose Escalation Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Conditions: Intraocular Melanoma
1 Location available
- Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Conditions: Recurrent Melanoma - Stage IV Melanoma
1 Location available
- PET Imaging of Patients With Melanoma Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
Conditions: Newly Diagnosed or Recurrent Metastatic Melanoma Patients
1 Location available
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Conditions: Metastatic Melanoma
1 Location available
- A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma
Conditions: Malignant Melanoma
1 Location available
- Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Conditions: Metastatic Melanoma - Renal Cell Cancer
1 Location available
- Melanoma Biomarker Study
Conditions: Metastatic Melanoma
1 Location available
- Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Conditions: Metastatic Melanoma
1 Location available
- Evaluation of Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy
Conditions: Metastatic Melanoma
1 Location available
- Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
Conditions: Metastatic Melanoma - Metastatic Renal Cell Cancer - Metastatic Cancer
1 Location available
- Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Melanoma
Conditions: Metastatic Melanoma - Cutaneous Melanoma
2 Locations available
- Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Conditions: Malignant Melanoma, Metastatic
1 Location available
- Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutatio
Conditions: Malignant Melanoma
2 Locations available
- A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With INCB024360 or Placebo in Subjects With Unresectable or Met
Conditions: Metastatic Melanoma
2 Locations available
- Clinical Trial of Sutent to Treat Metastatic Melanoma
Conditions: Metastatic Melanoma
1 Location available
- Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
Conditions: Metastatic Melanoma - Absence of CNS Metastases
1 Location available
- Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Conditions: Mucosal Melanoma - Acral Melanoma - Melanoma
8 Locations available
- Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Conditions: Recurrent Melanoma - Stage IV Melanoma
1 Location available
- Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
Conditions: Metastatic Melanoma
1 Location available
- Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
Conditions: Melanoma
2 Locations available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
Conditions: Metastatic Cancer - Melanoma
1 Location available
- Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Conditions: Intraocular Melanoma
1 Location available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
Conditions: Metastatic Malignant Uveal Melanoma
4 Locations available
- Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
1 Location available
- Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Conditions: Melanoma
1 Location available
- Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Conditions: Advanced Non-hematologic Malignancies - Advanced Metastatic Melanoma
2 Locations available
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
220 Locations available
- A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Conditions: Melanoma
16 Locations available
- Panobinostat (LBH589) in Patients With Metastatic Melanoma
Conditions: Melanoma - Malignant Melanoma
1 Location available
- STA-9090 in Metastatic Ocular Melanoma
Conditions: Ocular Melanoma
2 Locations available
|